New Rochelle, NY, February 11, 2013--When the time comes for postmenopausal women to discontinue hormone therapy (HT), little is known about the best way to do so with minimal symptoms. A new study that explores optimal approaches to manage symptoms such as trouble sleeping, mood swings, and depression on discontinuation of HT is published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website at http://www.
Many women will try and fail to stop using hormone pills and patches intended to control menopausal symptoms, according to Katherine Newton, PhD and coauthors, Group Health Research Institute, University of Washington, UW School of Medicine, and Fred Hutchinson Cancer Research Institute, Seattle, and Harvard Medical School and Harvard Vanguard Medical Associates, Boston, MA.
They identify several characteristics of hormone therapy cessation that can increase the likelihood of its success in the article "Factors Associated with Successful Discontinuation of Hormone Therapy." Among these are the positive effects of a physician's advice and the importance of symptom management.
"It is important that we better understand experiences, practices, and attitudes related to discontinuation of hormone therapy in the post-Women's Health Initiative (WHI) era," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.
About the Journal
Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website at http://www.
About the Academy
Academy of Women's Health is an interdisciplinary, international association of physicians, nurses, and other health professionals who work across the broad field of women's health, providing its members with up-to-date advances and options in clinical care that will enable the best outcomes for their women patients. The Academy's focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment of women across the lifespan. Journal of Women's Health and the Academy of Women's Health are co-presenters of Women's Health 2014: The 22nd Annual Congress which will take place April 4-6, 2014 in Washington, DC.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Population Health Management, Journal of Men's Health, Metabolic Syndrome and Related Disorders, and Breastfeeding Medicine. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at http://www.
Mary Ann Liebert, Inc.
140 Huguenot Street, New Rochelle, NY 10801
Phone: (914) 740-2100
Fax (914) 740-2101